Overview

Update
Total Equity Funding
$76.8M in 5 Rounds from 2 Investors
Most Recent Funding
$1.8M Convertible Note on February 4, 2016
Headquarters:
Ann Arbor, Michigan
Description:
NanoBio is a biopharmaceutical company focused on developing products for the prevention and treatment of infectious diseases.
Founders:
Categories:
Biotechnology, Medical, Nanotechnology
Website:
http://www.nanobio.com
Social:

Company Details

Update

NanoBio® Corporation is a privately-held biopharmaceutical company focused on developing and commercializing novel products for the prevention and treatment of infectious diseases, based on its patented NanoStat™ technology platform.

Founded in 2000 as a spin-out from the Center for Biologic Nanotechnology at the University of Michigan, NanoBio’s lead product candidates target treatments for herpes labialis (cold sores), onychomycosis (nail fungus), vaginitis, cystic fibrosis and intranasal & intramuscular vaccines for influenza, RSV, HSV2 and anthrax.

Funding Rounds (6) - $82.8M

Update
DateAmount / RoundValuationLead InvestorInvestors
Feb, 2016$1.8M / Convertible Note0
Nov, 2012$11M / Series C2
Nov, 2010$6M / Grant1
Jul, 2009$22M / Series B2
Feb, 2009$12M / Series B1
Oct, 2006$30M / Private Equity1

Current Team (11)

Update

Offices/Locations (1)

Update
  • Headquarters

    2311 Green Road

    Suite A

    Ann Arbor, Michigan 48105

    United States

Images (1)

Update

Add Acquisitions

Add Board Members and Advisors

Add Products

Add Sub Organizations

Add Competitors

Add Memberships

Add Customers

Add Partners

Add Videos